Glibenclamide + Metformin + Rosiglitazone is a combination of oral antidiabetic medicines used to manage type 2 diabetes mellitus.
This combination is commonly used for:
• Type 2 diabetes mellitus: Helps control high blood sugar levels when diet, exercise, and dual therapy are not enough.
• Insulin resistance: Improves the body's sensitivity to insulin, helping cells use glucose more effectively.
Upper respiratory tract infection
Injury
Headache
Back pain
Hyperglycaemia
Glibenclamide + Metformin + Rosiglitazone combines three medicines that lower blood sugar through different mechanisms.
Glibenclamide is a sulfonylurea. It stimulates the pancreas to release more insulin, which helps move glucose out of the blood and into cells.
Metformin is a biguanide. It reduces the amount of glucose the liver produces and improves how the body responds to insulin.
Rosiglitazone is a thiazolidinedione. It makes muscle, fat, and liver cells more sensitive to insulin, helping them absorb more glucose from the blood.
Together, these three medicines target blood sugar from multiple angles, providing more comprehensive glycaemic control than a single medicine alone.

Doctor of Medicine

BAMS, FMC, MD Resident
Glibenclamide + Metformin + Rosiglitazone is available as an oral medication in tablet form.
This medicine is intended for use in adults only.
Glibenclamide + Metformin + Rosiglitazone is contraindicated in patients with Type 1 diabetes or diabetic ketoacidosis, severe renal impairment or renal disease, and acute or chronic metabolic acidosis. It is also contraindicated in individuals with known hypersensitivity to any of the components and in those with congestive heart failure of NYHA Class III or IV.
This combination may interact with other anti-diabetic agents (such as insulin), NSAIDs (like ibuprofen), sulfonylureas (such as glimepiride), thiazides (including hydrochlorothiazide), corticosteroids (such as prednisone), phenothiazines (like chlorpromazine), thyroid products (such as levothyroxine), oral contraceptives (like ethinylestradiol), and calcium channel blockers (such as amlodipine).
Taking more than the prescribed dose can cause severe hypoglycaemia (low blood sugar), lactic acidosis, or other serious symptoms. Seek medical help immediately if an overdose is suspected.
If you miss a dose, take it as soon as you remember. If it is nearly time for your next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
If experiencing mild digestive upset, consider taking the medication with food.
To manage mild headaches, ensure adequate hydration and take the medicine after a light meal.
This medication may impair your ability to drive or operate machinery. Do not drive or engage in activities requiring alertness if you feel dizzy or experience visual disturbances.
Glibenclamide + Metformin + Rosiglitazone is not recommended during pregnancy and lactation. The potential risks should be weighed against the benefits in consultation with your doctor.
Patients with liver disease should use Glibenclamide + Metformin + Rosiglitazone with caution. Regular monitoring of liver function tests is advisable.
It should be used cautiously in patients with a history of heart disease.
Follow a balanced diet rich in whole grains, vegetables, and lean proteins. Avoid excessive carbohydrates and sugar.
Maintain regular physical activity to help manage blood sugar levels—aim for at least 150 minutes of moderate exercise per week.
Monitor blood glucose regularly to assess the effectiveness of the medication and dietary adjustments.
Frequently asked questions
No, Glibenclamide + Metformin + Rosiglitazone is not a steroid. It is a combination medication used for the management of type 2 diabetes.
There are no direct effects of Glibenclamide + Metformin + Rosiglitazone on sleep mentioned in the sources. However, uncontrolled blood sugar levels can impact sleep patterns.
Rosiglitazone, an active ingredient in this combination, may result in ovulation in premenopausal anovulatory women, potentially affecting fertility.
The medication should be taken as an adjunct to diet and exercise to manage blood sugar levels. No specific food restrictions are mentioned, but a balanced, diabetic-friendly diet is recommended.
Yes, it is usually safe to take Glibenclamide + Metformin + Rosiglitazone daily, as per your doctor's recommendation.
The time taken for this combination to work can vary. Peak plasma concentrations for the individual components occur between 1 to 4 hours after ingestion.
This medication is typically taken with meals, as directed by your doctor.
Glibenclamide + Metformin + Rosiglitazone in other salts

Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorAdvertise with UsSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.28.9
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners

